| 000 | 01737 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517184340.0 | ||
| 264 | 0 | _c20190603 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a2452-3186 | ||
| 024 | 7 |
_a10.1016/j.retram.2017.10.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalem, R | |
| 245 | 0 | 0 |
_aProgressive multifocal leukoencephalopathy in patients receiving rituximab and cyclophosphamide after haplo-identical T-cell replete transplantation and review of the literature. _h[electronic resource] |
| 260 |
_bCurrent research in translational medicine _c11 2017 |
||
| 300 |
_a127-132 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aJC Virus _xphysiology |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _ximmunology |
| 650 | 0 | 4 |
_aLeukoencephalopathy, Progressive Multifocal _xdiagnosis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRituximab _xadministration & dosage |
| 650 | 0 | 4 |
_aTransplantation Conditioning _xadverse effects |
| 650 | 0 | 4 |
_aTransplantation, Haploidentical _xadverse effects |
| 650 | 0 | 4 |
_aVirus Activation _xdrug effects |
| 700 | 1 | _aMassoud, R | |
| 700 | 1 | _aKanj, S S | |
| 700 | 1 | _aHamdan, M | |
| 700 | 1 | _aSalman, R | |
| 700 | 1 | _aBazarbachi, A | |
| 700 | 1 | _aEl-Cheikh, J | |
| 773 | 0 |
_tCurrent research in translational medicine _gvol. 65 _gno. 4 _gp. 127-132 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.retram.2017.10.002 _zAvailable from publisher's website |
| 999 |
_c27783419 _d27783419 |
||